While DLO shows strong fundamentals with impressive 45% 3-year revenue growth, 34.4% ROE, and a recent positive catalyst (revenues breaking $1B), the price action reveals a concerning pattern that undermines near-term swing trade potential. The stock has been in a downtrend since early November 2025 (peaked at $16.78 in mid-October), and at $12.64 it is trading near 52-week lows despite the bullish revenue milestone—suggesting the market has already priced in or dismissed this news. The valuation metrics (P/E of 24.4, P/B of 6.56) are elevated for a financial services company in consolidation mode, and the recent price volatility shows failed rallies (multiple attempts to break above $14-15 have been rejected), indicating weak institutional demand. Over the 2-12 week horizon, the risk of further downside to test $11-12 support levels outweighs the upside potential, especially given the lack of a clear technical catalyst or reversal pattern; a more prudent entry would be after a confirmed bottom with volume confirmation or a break above the $15 resistance with conviction.

DLocal (DLO) is currently showing signs of a price floor around the $11.20-$12.00 range, and the recent climb to $12.64 suggests a reversal of the multi-month downtrend is underway. Fundamentally, the company remains highly profitable with a robust ROE of 34.4% and impressive long-term revenue growth, recently surpassing the $1 billion annual revenue milestone. The primary risks for this swing trade include the high beta of 1.12 and potential volatility inherent in emerging market financial services, which could lead to sharp pullbacks if broader market sentiment sours. However, with the stock trading significantly below its 52-week highs and showing renewed momentum on positive news, the verdict is a BUY with an estimated upside potential of 15-20% toward the $14.50-$15.00 resistance level within the 2-12 week window.

Price action: DLO recently bounced from the ~11.3 low and is trading around $12.6—just off a short-term support zone and below the prior resistance band at ~14.2–15.5, so there is a clear, tradable reward:risk to try to capture a retest of that resistance in the next 2–12 weeks. Fundamental health: the company looks healthy for a growth payments business — strong revenue growth (3Y 45%, 5Y 68%), solid margins (gross ~38.6%, net ~17.8%), high ROE (34%) and positive EPS, though valuation metrics (P/B ~6.6, P/E ~24) imply expectations are priced in. Key risks on the 2–12 week horizon: macro/market selloffs or risk-off flows, emerging-market FX or volume shocks that hit payment volumes, disappointing near-term guidance or earnings, and profit-taking after the recent revenue milestone headlines; liquidity/volatility can also produce rapid downside (support near $11 should be watched). Final verdict and upside: I recommend BUY as a short-term swing — target a move back into the $14.5–16.0 area (~+15% to +26% upside) while using a tight risk plan (stop in the $10.8–11.5 area) because failure to hold current support could see a 10–15% pullback.

Price action shows a recent bounce from a low of $11.37 on 2026-03-16 to $12.72 close on 2026-03-23, with the current price at $12.64 representing a minor pullback in an emerging uptrend after a broader decline from 2025 highs around $16, providing a solid entry point for swing trading upward momentum. Fundamentals are robust with 45.1% 3-year revenue growth, 34.4% ROE, 17.8% net margins, and a reasonable P/E of 24.4, indicating a healthy, high-growth fintech company in payments. Key risks over the 2-12 week horizon include high beta (1.12) amplifying market volatility, potential economic slowdowns impacting emerging markets exposure, and the stock's history of sharp corrections after rallies. Overall, BUY with estimated 15-25% upside potential to $15-$16, driven by positive revenue news breaking $1B and technical rebound.